https://www.indianpharmapost.com/sanofis-amlitelimab-delivers-in-phase-3-trials-heads-for-global-filings-189752026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/trelegy-ellipta-gets-green-light-in-china-for-adults-with-uncontrolled-asthma-189762026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/hongene-biotech-bags-gates-foundation-grant-to-boost-global-mrna-vaccine-access-189772026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/eastman-kolmar-korea-join-forces-to-deliver-biodegradable-beauty-breakthroughs-189782026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/ionis-and-otsuka-score-eu-nod-for-dawnzera-offering-new-hope-for-rare-hae-patients-189792026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/pangea-laboratory-teams-with-gene-solutions-to-bring-ai-driven-cancer-tests-to-us-patients-189802026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/parse-biosciences-unveils-integrated-immune-profiling-in-trailmaker-platform-189812026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/truvian-health-bags-fda-clearance-for-cbc-on-truverus-system-189822026-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/eu-green-light-to-intrabios-aqneursa-for-rare-neurological-disease-niemann-pick-type-c-189832026-01-28T00:00:00+05:30always0.9